PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
06-May-2026 Cencora Reports Fiscal 2026 Second Quarter Results Businesswire
06-May-2026 Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Businesswire
06-May-2026 University of Huddersfield research to create 3D bioengineered wound models for healthcare training recognised with Society of Tissue Viability awards University of Huddersfield
06-May-2026 Patients benefit as the Royal Hospital for Neuro-disability introduces innovative predictive technology to support earlier recognition of infection risk Sanome
06-May-2026 BeOne Medicines Announces First Quarter 2026 Financial Results and Business Updates Businesswire
06-May-2026 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
06-May-2026 FUJIFILM Biosciences and NextCell Launch New Commercial Platform Comprised of RUO Stromal Cells and Cell Culture Media Businesswire
06-May-2026 Hidden Inflammation Around Breast Implants Karl Landsteiner University
06-May-2026 Announcement from the Annual General Meeting of Vicore Pharma Holding AB (publ) ACCESS Newswire
06-May-2026 Cosmos Health Introduces Fort18 in the United States - A Men's Sexual Stamina Supplement Expanding the 18 Series into Men's Wellness ACCESS Newswire
06-May-2026 Durbin PLC becomes Uniphar, bolstering medicine access amidst growing healthcare demands Uniphar
06-May-2026 Nurses Week Report: FBI Cyber Warning Puts Hospital Nurses' Downtime Readiness in Focus ACCESS Newswire
06-May-2026 Bayer to Acquire Perfuse Therapeutics to Complement Ophthalmology Pipeline Businesswire
06-May-2026 Vitalant and San Diego  Blood Bank Complete Strategic Merger Vitalant
06-May-2026 Link Biologics strengthens IP position for Link_TSG6 with US patent Notice of Allowance and University of Manchester IP assignment Link Biologics
06-May-2026 New scientific article published on TrkA-NAM ACD137 against osteoarthritic pain AlzeCure Pharma AB
06-May-2026 Spago Nanomedical's phase I/IIa study Tumorad-01 meets a primary endpoint and provides further visible tumor uptake Spago Nanomedical
06-May-2026 Jaguar Health Announces Preliminary Discussion with FDA to Evaluate Breakthrough Therapy Designation for Crofelemer for Treatment of Microvillus Inclusion Disease (MVID) ACCESS Newswire
06-May-2026 Signadori Bio Raises €11 Million Seed Round to Advance Next-Generation Solid Tumour Platform Businesswire
06-May-2026 New Membrane Technology Hub is Tackling Cancer Drugs, Carbon Capture and the Global Water Crisis Crowdhelix